Sector News

Latest News: Life sciences

November 22, 2019
Life sciences

When Amgen said it would hand over $13.4 billion for Celgene’s hit psoriasis drug Otezla in August, analysts agreed it had overpaid by $2 billion. But they also predicted Amgen’s […]

November 21, 2019
Life sciences

Sanofi CEO Paul Hudson has been on the job for just over two months, and he’s prepping for a big strategy reveal next month. One thing that might be behind […]

November 21, 2019
Life sciences

Shares in The Medicines Company have leapt on rumours that Novartis is eyeing a takeover of the company and its promising new cardiovascular drug inclisiran. A report from Bloomberg also […]

November 20, 2019
Life sciences

The drug patent system was created to reward pharma companies for innovation and ensure returns on investment, but increasingly companies are manipulating the system using techniques like ‘evergreening’ and ‘thicketing’ […]

November 20, 2019
Life sciences

Amgen’s top line has suffered from knockoff competition in recent quarters, and now the pain is moving to its payroll. After disclosing almost 150 cuts on the East Coast last […]

Subscribe to our Weekly Newsletter

We're easy to reach